PMID- 23674394 OWN - NLM STAT- MEDLINE DCOM- 20141223 LR - 20140408 IS - 1098-1063 (Electronic) IS - 1050-9631 (Linking) VI - 23 IP - 10 DP - 2013 Oct TI - Blockade of BDNF signaling turns chemically-induced long-term potentiation into long-term depression. PG - 879-89 LID - 10.1002/hipo.22144 [doi] AB - Long-term potentiation (LTP) is accompanied by increased spine density and dimensions triggered by signaling cascades involving activation of the neurotrophin brain-derived neurotrophic factor (BDNF) and cytoskeleton remodeling. Chemically-induced long-term potentiation (c-LTP) is a widely used cellular model of plasticity, whose effects on spines have been poorly investigated. We induced c-LTP by bath-application of the N-methyl-d-aspartate receptor (NMDAR) coagonist glycine or by the K(+) channel blocker tetraethylammonium (TEA) chloride in cultured hippocampal neurons and compared the changes in dendritic spines induced by the two models of c-LTP and determined if they depend on BDNF/TrkB signaling. We found that both TEA and glycine induced a significant increase in stubby spine density in primary and secondary apical dendrites, whereas a specific increase in mushroom spine density was observed upon TEA application only in primary dendrites. Both TEA and glycine increased BDNF levels and the blockade of tropomyosin-receptor-kinase receptors (TrkRs) by the nonselective tyrosine kinase inhibitor K-252a or the selective allosteric TrkB receptor (TrkBR) inhibitor ANA-12, abolished the c-LTP-induced increase in spine density. Surprisingly, a blockade of TrkBRs did not change basal spontaneous glutamatergic transmission but completely changed the synaptic plasticity induced by c-LTP, provoking a shift from a long-term increase to a long-term depression (LTD) in miniature excitatory postsynaptic current (mEPSC) frequency. In conclusion, these results suggest that BDNF/TrkB signaling is necessary for c-LTP-induced plasticity in hippocampal neurons and its blockade leads to a switch of c-LTP into chemical-LTD (c-LTD). CI - Copyright (c) 2013 Wiley Periodicals, Inc. FAU - Montalbano, A AU - Montalbano A AD - Department of Life Sciences and B.R.A.I.N., Centre for Neuroscience, University of Trieste, Trieste, Italy. FAU - Baj, G AU - Baj G FAU - Papadia, D AU - Papadia D FAU - Tongiorgi, E AU - Tongiorgi E FAU - Sciancalepore, M AU - Sciancalepore M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130626 PL - United States TA - Hippocampus JT - Hippocampus JID - 9108167 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Glycine Agents) RN - 0 (Potassium Channel Blockers) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 66-40-0 (Tetraethylammonium) RN - EC 2.7.10.1 (Receptor, trkB) RN - TE7660XO1C (Glycine) SB - IM MH - Animals MH - Brain-Derived Neurotrophic Factor/antagonists & inhibitors/*metabolism MH - Cells, Cultured MH - Dendritic Spines/drug effects/*physiology MH - Excitatory Postsynaptic Potentials/drug effects MH - Glycine/pharmacology MH - Glycine Agents/pharmacology MH - Hippocampus/cytology/*metabolism MH - Long-Term Potentiation/drug effects/*physiology MH - Long-Term Synaptic Depression/drug effects/*physiology MH - Patch-Clamp Techniques MH - Potassium Channel Blockers/pharmacology MH - Rats, Wistar MH - Receptor, trkB/antagonists & inhibitors/*metabolism MH - Receptors, N-Methyl-D-Aspartate/agonists MH - Signal Transduction/drug effects/*physiology MH - Tetraethylammonium/pharmacology OTO - NOTNLM OT - TEA; glycine OT - chemical LTD OT - chemical LTP OT - spine remodeling EDAT- 2013/05/16 06:00 MHDA- 2014/12/24 06:00 CRDT- 2013/05/16 06:00 PHST- 2013/05/01 00:00 [accepted] PHST- 2013/05/16 06:00 [entrez] PHST- 2013/05/16 06:00 [pubmed] PHST- 2014/12/24 06:00 [medline] AID - 10.1002/hipo.22144 [doi] PST - ppublish SO - Hippocampus. 2013 Oct;23(10):879-89. doi: 10.1002/hipo.22144. Epub 2013 Jun 26.